Citadel Advisors LLC 13D and 13G filings for Genocea Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 06:19 am Sale |
2021-12-31 | 13G | Genocea Biosciences, Inc. GNCA |
Citadel Advisors LLC | 3,535,358 6.200% |
-51,718 (-1.44%) |
Filing |
| 2021-02-16 4:30 pm Purchase |
2020-12-31 | 13G | Genocea Biosciences, Inc. GNCA |
Citadel Advisors LLC | 3,587,076 6.700% |
154,690 (+4.51%) |
Filing |
| 2020-07-31 4:31 pm Purchase |
2020-07-22 | 13G | Genocea Biosciences, Inc. GNCA |
Citadel Advisors LLC | 3,432,386 6.500% |
3,432,386 (New Position) |
Filing |